CN106511132A - Anticorrosion system of infant wet tissue immersion liquid and preparation method thereof - Google Patents
Anticorrosion system of infant wet tissue immersion liquid and preparation method thereof Download PDFInfo
- Publication number
- CN106511132A CN106511132A CN201611093976.3A CN201611093976A CN106511132A CN 106511132 A CN106511132 A CN 106511132A CN 201611093976 A CN201611093976 A CN 201611093976A CN 106511132 A CN106511132 A CN 106511132A
- Authority
- CN
- China
- Prior art keywords
- parts
- stand
- solution
- preparation
- dissolved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention relates to anticorrosion system of infant wet tissue immersion liquid and a preparation method thereof. The anticorrosion system is prepared by mixing 0.5 to 1 part of paeonol, 15 to 20 parts of propanediol, 0.4 to 1 part of eucalyptus oil, 0.8 to 1.5 parts of eugenol, 0.01 to 0.02 part of tea tree oil, 10 to 15 parts of hydrogenated castor oil (PEG-40), 1 to 2.5 parts of sodium hexametahposphate, 0.01 to 0.05 part of Epsilon-polylysine, 0.02 to 0.05 part of natamycin and 60 to 72 parts of deionized water. Chemical bactericides, chemical fungistats and chemical bacterial inhibitors are not used; the safety is high; and sterilization, fungus inhibition and bacterium inhibition properties are good.
Description
Technical field
The present invention relates to the protective system of wet paper immersion, more particularly to the anti-corrosion body of infant wet paper immersion
System and preparation method.
The protective system of wet paper immersion is the main base fluid of wet tissue, can allocate other functional raw materials on this basis into, such as：
Skin care ingredient, spice is added both to make the wet tissue with skin-protecting function and fragrance.
Background technology
The immersion protective system of infant wet tissue is consistent with wet paper immersion protective system with adult on the market now, both makes
Use chemical preservative.Wherein antibacterial includes：Benzethonium chloride, benzalkonium chloride, polyhexamethylene guanidine, polyquaternary ammonium salt, chlorine hydroxyl hexichol
Ether（Triclosan）Deng.Fungistat includes：Iodine propilolic alcohol butyl mephenesin Carbamate（IPBC), propyl hydroxybenzoate（Propylparaben）
Deng.Bacterial inhibitor includes：Bronopol, methyl hydroxybenzoate（Nipagin ester methyl ester）, phenoxyethanol etc..
Using chemical preservative because its toxic and side effects is big and zest strong, it is unsuitable for infant product.Some of which country
Child's use is prohibited, some are that the countries such as European Union forbid or limit the quantity use.
When using wiping, wet paper immersion can be stayed on human skin wet tissue, the toxic and side effects of chemical preservative and stimulation
Property, the tender and lovely skin of infant is damaged.Meanwhile, contain substantial amounts of water in wet tissue, there is bacterium dye in storage and use
And the problem of bacterium breeding, this requires that the protective system of infant wet paper immersion should have a safety, but also will to antibacterial and
The suppression of funguses kills effective.
201610219669.9 disclose special skin moistening wet tissue of a kind of women and infants and preparation method thereof, its main component：Essence
Controlling the water circulation 85-95%, mandarin oil 0.02-0.5%, chamomile essential oil 0.03-0.5%, Aloe extract 1-7%, glycerol 1-7%, preservative
0.05-0.2%, nonionic surfactant 1-3%, glyceryl stearate 0.5-5%, cetearyl alcohol 0.5-3%, Dormant oils 0.5-2%
With milk 0.5-2%.The preservative is the one kind in methyl parahydroxybenzoate, phenyl phenol and nipalgin.
CN201510734490.2 discloses a kind of pasteurization towelette, its wet tissue liquid by sodium lactate, tartaric acid, polyquaternary ammonium salt-
7th, dehydroactic acid sodium and pure water composition.
CN201410520932.9 discloses a kind of traditional Chinese medicine wet tissue, and its wet tissue liquid is by Flos Jasmini Sambac extract 3-9%, Aloe juice
0.5-2%, matrine 0.01-0.1%, Flos Pelargonii Hortori 0.05-0.2%, Propylene Glycol 1-5%, P-hydroxybenzoic acid first
Ester sodium 0.05-0.4%, surplus ultra-pure water composition.
CN201410647761.6 discloses a kind of infant handss mouth wet tissue, and which is by cucumber extract 0.2- 2, the hydration moon
Osmanthus acylsarcosine sodium 0.1-5, Disodium N-Coco acy-L-Glutamate 0.1-5, polyoxyethylene caprylic/glycerol decanoate 0.2-2, three
Chlorine life 0.05-0.3, glycerol 4-12, Jojoba oil 1-5, soluble metyl hydroxybenzoate 0.2- 0.6.
Above-mentioned prior art, using chemical preservative.
The content of the invention
It is an object of the invention to provide a kind of protective system of infant wet paper immersion and preparation method thereof, with natural component
As preservative, there is no toxicity and zest to infant.
The protective system preparation method of infant wet paper immersion of the present invention:
Raw material is by weight ratio：
(1), after by paeonol 0.5-1 parts, the mixing of Propylene Glycol 4-6 part, all dissolve in 20 DEG C of -40 DEG C of stirrings, be subsequently adding Folium eucalypti globueli (Eucalyptus globulus Labill.)
Oily 0.4-1 parts, eugenol 0.8-1.5 parts, tea tree oil 0.01-0.02 parts, add Propylene Glycol 11-15 part, stir, then plus
Enter castor oil hydrogenated (PEG-40) 10-15 parts, stir to transparent liquid, it is stand-by；
(2) sodium hexameta phosphate 1-2.5 part deionized waters 4-6 part is dissolved, it is stand-by；
(3) it is by ε-poly-D-lysine 0.01-0.05 part deionized waters 4-6 part dissolving, stand-by；
(4) natamycin 0.02-0.05 part deionized waters 4-6 part is dissolved, it is stand-by；
(5) it is put in a reservoir from water 43-58 parts, the solution that step 1 is obtained is poured under stirring, stirred；
(6) sequentially or simultaneously the solution that step 2, step 3, step 4 are obtained is added in step 5 solution and is stirred, must be produced
Product.
It is an advantage of the invention that：
1st, eugenol, eucalyptus oil are used as antibacterial, and which is extracted form natural plant quintessence oil, are had no toxic side effect safe, and
And zest is less than.Eugenol has to S. aureus L-forms, escherichia coli high kills effect.The benefit that eugenol is matched with eucalyptus oil
It is that weak tendency is killed in suppression in terms of eucalyptus oil can make up eugenol to gram positive bacteria, gram negative bacteria.The two collocation, can expand
Big sterilization bacterium spectrum.
2nd, natamycin：It is a kind of natural antifungal compound produced by streptomycete fermentation, belongs to polyene macrolide
Class, is acted on the sterol compound on fungal cell membrane by its lactone ring structure, causes the materials such as aminoacid in bacterium, electrolyte
Ooze out, it is dead to thalline.Therefore, natamycin can effectively suppress various mycetes, saccharomycetic growth, can suppress funguses poison again
The generation of element, therefore using natamycin as main fungistat.But find that natamycin there are suppression funguses in an experiment
Time short shortcoming, Jing repetition tests add tea tree oil extend the mycostatic time of natamycin.Tea tree oil is from port wood
The Pure natural plant essential oil extracted in Myrtaceae Folium Melaleucae Leucadendrae, itself just has broad-spectrum antibacterial action, can be to golden yellow Portugal
Grape coccus, escherichia coli, Candida albicans, gram positive bacteria and gram negative bacteria etc. have inhibitory or killing effect, and itself is to kill
Microbial inoculum but with the use in conjunction of natamycin after, strengthen to fungi restraining effect.Its use in conjunction effect is better than iodine propilolic alcohol fourth
Base mephenesin Carbamate（), IPBC iodine propilolic alcohol butyl mephenesin Carbamate（IPBC), have carcinogenesis, country explicit order 3 years old with
Lower child prohibits the use of.
3rd, ε-poly-D-lysine is natural biological preparation, and its safety first is very high, can be divided after people is edible in human body
Solution aminoacid, participates in body metabolism, without any toxicity.Secondly, to gram positive bacteria, gram negative bacteria, yeast, mycete
There is good fungistatic effect, be mainly used in food preservative.3rd, ε-poly-D-lysine can suppress thermostability bacillus cereuss
Propagation, strengthen bacteriostasis.But the present invention is another characteristic using it, the material with anion is had very using it
Strong electrostatic force and there is good penetration power to biomembrane, based on this characteristic using ε-poly-D-lysine as Flos Caryophylli
The carrier of phenol, Folium eucalypti globueli (Eucalyptus globulus Labill.) oil bactericide, accelerates eugenol, eucalyptus oil and enters inside antibacterial, that is, shorten sterilization approach, increase substantially
Eradicative rate.The biocidal efficacies of 1+1 ＞ 2 are played with the compatibility of eugenol, eucalyptus oil.
4th, paeonol is that, by the extract of Paeonia suffruticosa rhizome, it is to white grape coccus, bacillus subtilis, escherichia coli, typhoid fever bar
Bacterium etc. has stronger antibacterial ability, plays cooperative compensating effect with antibacterial eugenol, eucalyptus oil.
The present invention does not use chemical bactericide and Chemical fungal inhibitor and chemico-bacterial inhibitor, safe, sterilization,
Antibacterial, fungicidal properties is good.
Specific embodiment
Embodiment 1：
(1), after mixing paeonol 0.5, Propylene Glycol 4, all dissolve in 20 DEG C of -40 DEG C of stirrings, be subsequently adding eucalyptus oil 1, Flos Caryophylli
Phenol 0.8, tea tree oil 0.02, add Propylene Glycol 11, stir, and add castor oil hydrogenated (PEG-40) 10, stir to saturating
Bright liquid, it is stand-by；
(2) 1 deionized water 4 of sodium hexameta phosphate is dissolved, it is stand-by；
(3) 0.05 deionized water 6 of ε-poly-D-lysine is dissolved, it is stand-by；
(4) 0.02 deionized water 4 of natamycin is dissolved, it is stand-by；
(5) it is put in a reservoir and the solution that step 1 is obtained is poured under stirring from water 58, stirs；
(6) successively the solution that step 2, step 3, step 4 are obtained is added in step 5 solution and is stirred, obtain product.
Embodiment 2：
(1), after mixing paeonol 0.6, Propylene Glycol 4.5, all dissolve in 20 DEG C of -40 DEG C of stirrings of temperature, be subsequently adding eucalyptus oil
0.8th, eugenol 1.4, tea tree oil 0.01, add Propylene Glycol 15, stir, and add castor oil hydrogenated (PEG-40) 12,
Stir to transparent liquid, it is stand-by；
(2) 2 deionized water 4.5 of sodium hexameta phosphate is dissolved, it is stand-by；
(3) 0.02 deionized water 4 of ε-poly-D-lysine is dissolved, it is stand-by；
(4) 0.04 deionized water 5 of natamycin is dissolved, it is stand-by；
(5) it is put in a reservoir and the solution that step 1 is obtained is poured under stirring from water 50, stirs；
(6) successively the solution that step 2, step 3, step 4 are obtained is added in step 5 solution and is stirred, obtain product.
Embodiment 3：
(1), after mixing paeonol 0.7, Propylene Glycol 5, all dissolve in 20 DEG C of -40 DEG C of stirrings, be subsequently adding eucalyptus oil 0.5, fourth
Fragrant phenol 1.2, tea tree oil 0.015, add Propylene Glycol 14, stir, and add castor oil hydrogenated (PEG-40) 14, stirring
It is to transparent liquid, stand-by；
(2) 1.5 deionized water 5 of sodium hexameta phosphate is dissolved, it is stand-by；
(3) 0.025 deionized water 4.5 of ε-poly-D-lysine is dissolved, it is stand-by；
(4) 0.05 deionized water 6 of natamycin is dissolved, it is stand-by；
(5) it is put in a reservoir and the solution that step 1 is obtained is poured under stirring from water 48, stirs；
(6) successively the solution that step 2, step 3, step 4 are obtained is added in step 5 solution and is stirred, obtain product.
Embodiment 4：
(1), after mixing paeonol 0.85, Propylene Glycol 5.5, all dissolve in 20 DEG C of -40 DEG C of stirrings, be subsequently adding eucalyptus oil
0.72nd, eugenol 1, tea tree oil 0.018, add Propylene Glycol 12, stir, and add castor oil hydrogenated (PEG-40)) 13,
Stir to transparent liquid, it is stand-by；
(2) 2.4 deionized water 5.5 of sodium hexameta phosphate is dissolved, it is stand-by；
(3) 0.04 deionized water 5 of ε-poly-D-lysine is dissolved, it is stand-by；
(4) 0.03 deionized water 4.5 of natamycin is dissolved, it is stand-by；
(5) it is put in a reservoir and the solution that step 1 is obtained is poured under stirring from water 49, stirs；
(6) successively the solution that step 2, step 3, step 4 are obtained is added in step 5 solution and is stirred, obtain product.
Embodiment 5：
(1), after mixing paeonol 1, Propylene Glycol 6, all dissolve in 20 DEG C of -40 DEG C of stirrings, be subsequently adding eucalyptus oil 0.4, Flos Caryophylli
Phenol 1.5, tea tree oil 0.02, add Propylene Glycol 14, stir, and add castor oil hydrogenated (PEG-40) 15, stir to saturating
Bright liquid, it is stand-by；
(2) 2.5 deionized water 6 of sodium hexameta phosphate is dissolved, it is stand-by；
(3) 0.01 deionized water 6 of ε-poly-D-lysine is dissolved, it is stand-by；
(4) 0.025 deionized water 4.5 of natamycin is dissolved, it is stand-by；
(5) it is put in a reservoir and the solution that step 1 is obtained is poured under stirring from water 43, stirs；
(6) stir in solution addition step 5 solution that 2 steps, 3 steps, 4 steps are obtained while pouring into, obtain product.
Biocidal property detection is carried out to examples detailed above 1-5 product, it is as a result as follows.
According to《Disinfection technology standard》Regulation is detected that testing result antibacterial circle diameter is all higher than 7 mm, meets state's domestic discipline and family rules
It is fixed, that is, it is judged to there are bacteriostasis.
Escherichia coli（China Committee for Culture Collection of Microorganisms's common micro-organisms center）8th generation.
Staphylococcus aureuses ATCC 6538（China Committee for Culture Collection of Microorganisms's common micro-organisms center）The
4 generations.
Candida albicans ATCC 10231（China Committee for Culture Collection of Microorganisms's common micro-organisms center）8th
Generation.
9027 (China Committee for Culture Collection of Microorganisms's common micro-organisms centers of pseudomonas aeruginosa ATCC）
6th generation.
Above-mentioned enforcement 1-5 example products of the invention are made into wet tissue, wet tissue product is detected：
Use spun laced fabric（Long 155mm × wide 200mm cotton contents 9:1）, 3 grams of water/pieces of immersion, 80/often wrap, plastic bag sealing bag
Dress；
38 DEG C of temperature is placed, three months in the baking oven of humidity 50%；
Wet tissue is detected as follows.
1 bacterial micro-organism testing result is as follows.
Foundation《Disposable Sanitary Accessory sanitary standard》GB15975-2002 specifies.
2 pairs of colibacillary bactericidal assay results are as follows.
Note：The equal asepsis growth of negative control group.
Escherichia coli（China Committee for Culture Collection of Microorganisms's common micro-organisms center）8th generation.
According to National Standard of the People's Republic of China《Disposable Sanitary Accessory standard》GB15979-2002, example 1-
It is 98.62 that 5 products act on the average bactericidal rate of 2min to escherichia coli, meets national requirements.
3 pairs of staphylococcus aureuses bactericidal assay results are as follows.
Note：The equal asepsis growth of negative control group.
Staphylococcus aureuses ATCC 6538（China Committee for Culture Collection of Microorganisms's common micro-organisms center）The
4 generations.According to National Standard of the People's Republic of China《Disposable Sanitary Accessory standard》GB15979-2002, example 1-5 are produced
It is 97.31 that product act on the average bactericidal rate of 2min to staphylococcus aureuses, meets national regulation.
4 pairs of Candida albicans bactericidal assay results are as follows.
Note：The equal asepsis growth of negative control group.
Candida albicans ATCC 10231（China Committee for Culture Collection of Microorganisms's common micro-organisms center）8th
Generation.According to National Standard of the People's Republic of China《Disposable Sanitary Accessory standard》GB15979-2002, example 1-5 products
The average bactericidal rate that Candida albicans are acted on 2min is 95.27, meets national requirements.
5 irritation tests：
Foundation《Disinfection technology standard》Defend method prison to send out（2002）No. 282-2.3.3.
Method：Before test, the hair of rabbit back both sides skin is dispelled by 24h, unhairing 3 × 3cm of scope2, left side control（Control
Thing is normal saline, the same test block of test method）, the right is test block, 2.5 × 2.5 cm of next day clip2The sample of size, applies
It is attached to test block.Then with one layer of non-stimulated plastics membrane cover.Fixed with nonirritant adhesive plaster again, closed 4h, removed residual
Tested material.1h, 24h, 48h after tested material is removed checks rabbit skin reaction.Carry out skin wound repair scoring.
Skin Irritation Test result is as follows（Example 1-5 is done experiment respectively）.
Conclusion：In example 1-5 product testings, rabbit skin is without exception, and skin irritation index is 0.Meet national regulation.
Claims (2)
1. the protective system preparation method of infant wet paper immersion, is characterized in that：
Raw material is by weight ratio：
(1), after by paeonol 0.5-1 parts, the mixing of Propylene Glycol 4-6 part, all dissolve in 20 DEG C of -40 DEG C of stirrings, be subsequently adding Folium eucalypti globueli (Eucalyptus globulus Labill.)
Oily 0.4-1 parts, eugenol 0.8-1.5 parts, tea tree oil 0.01-0.02 parts, add Propylene Glycol 11-15 part, stir, then plus
Enter castor oil hydrogenated (PEG-40) 10-15 parts, stir to transparent liquid, it is stand-by；
(2) sodium hexameta phosphate 1-2.5 part deionized waters 4-6 part is dissolved, it is stand-by；
(3) it is by ε-poly-D-lysine 0.01-0.05 part deionized waters 4-6 part dissolving, stand-by；
(4) natamycin 0.02-0.05 part deionized waters 4-6 part is dissolved, it is stand-by；
(5) it is put in a reservoir from water 43-58 parts, the solution that step 1 is obtained is poured under stirring, stirred；
(6) sequentially or simultaneously the solution that step 2, step 3, step 4 are obtained is added in step 5 solution and is stirred, must be produced
Product.
2. the protective system of the infant wet paper immersion that claim 1 preparation method is obtained.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611093976.3A CN106511132A (en) | 2016-12-02 | 2016-12-02 | Anticorrosion system of infant wet tissue immersion liquid and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611093976.3A CN106511132A (en) | 2016-12-02 | 2016-12-02 | Anticorrosion system of infant wet tissue immersion liquid and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106511132A true CN106511132A (en) | 2017-03-22 |
Family
ID=58354272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611093976.3A Pending CN106511132A (en) | 2016-12-02 | 2016-12-02 | Anticorrosion system of infant wet tissue immersion liquid and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106511132A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107349118A (en) * | 2017-06-20 | 2017-11-17 | 铜陵麟安生物科技有限公司 | A kind of new formulation for pasteurization towelette thimerosal |
| CN109673919A (en) * | 2018-12-04 | 2019-04-26 | 杭州富特名食品科技有限公司 | Calgon enhances epsilon-polylysine or the application of its hydrochloride biocidal property |
| CN110279614A (en) * | 2019-07-17 | 2019-09-27 | 深圳市兴业卓辉实业有限公司 | A kind of natural modified antimicrobial composition, preparation method and wet tissue for wet tissue |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101214355A (en) * | 2007-12-29 | 2008-07-09 | 西北农林科技大学 | Compound eugenol nano emulsion composition and preparation thereof |
| CN101940225A (en) * | 2010-09-21 | 2011-01-12 | 福州圣德莉信息技术有限公司 | Compound antibacterial agent and preparation method thereof |
| CN104473800A (en) * | 2014-11-20 | 2015-04-01 | 柳江县联华纸制品厂 | Baby wipes |
-
2016
- 2016-12-02 CN CN201611093976.3A patent/CN106511132A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101214355A (en) * | 2007-12-29 | 2008-07-09 | 西北农林科技大学 | Compound eugenol nano emulsion composition and preparation thereof |
| CN101940225A (en) * | 2010-09-21 | 2011-01-12 | 福州圣德莉信息技术有限公司 | Compound antibacterial agent and preparation method thereof |
| CN104473800A (en) * | 2014-11-20 | 2015-04-01 | 柳江县联华纸制品厂 | Baby wipes |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107349118A (en) * | 2017-06-20 | 2017-11-17 | 铜陵麟安生物科技有限公司 | A kind of new formulation for pasteurization towelette thimerosal |
| CN109673919A (en) * | 2018-12-04 | 2019-04-26 | 杭州富特名食品科技有限公司 | Calgon enhances epsilon-polylysine or the application of its hydrochloride biocidal property |
| CN110279614A (en) * | 2019-07-17 | 2019-09-27 | 深圳市兴业卓辉实业有限公司 | A kind of natural modified antimicrobial composition, preparation method and wet tissue for wet tissue |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6626902B2 (en) | Antimicrobial herbal composition, method for producing and using the same | |
| CN104958248A (en) | Biological antibacterial composition and application of biological antibacterial composition in cosmetics | |
| CN104922055A (en) | Semifluid composition used for lubrication, moisture retention, disinfection and sterilization and application method thereof | |
| JP6073354B2 (en) | Skin preparation for external use with excellent antiseptic properties | |
| US20100160454A1 (en) | Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products | |
| JP5302239B2 (en) | Antiseptic disinfectant and human body composition | |
| CN108113894A (en) | A kind of infant's activity milky lotion and preparation method thereof | |
| CN106511132A (en) | Anticorrosion system of infant wet tissue immersion liquid and preparation method thereof | |
| CN108014032A (en) | A kind of hip pad wet tissue and preparation method thereof | |
| KR101637167B1 (en) | Antibacterials composition comprising Sedum extract composition and food additives and preparation method thereof | |
| KR102272901B1 (en) | Composition for external application to the skin containing meso-2,3-butanediol as a preservative | |
| JP2020164548A (en) | Composition containing meso-2,3-butanediol | |
| KR20150058604A (en) | Antiseptic composition for water tissue | |
| KR102412958B1 (en) | Antibacterial or conservative composition containing polyglycerine-3 | |
| KR101779131B1 (en) | A preservative for skin external application, and a cosmetic composition and a pharmaceutical composition comprising the same | |
| CN108125797A (en) | A kind of hand mouth wet tissue and preparation method thereof | |
| KR102102253B1 (en) | Skin external composition having excellent bactericidal activities | |
| CN110227071B (en) | Compound borneol antibacterial agent | |
| KR102394531B1 (en) | Antiseptic containing caprylic/capric glycerides and composition for skin external application containing thereof | |
| CN104207971B (en) | Medical skin-disinfection and -nursing hand-cleaning liquid and preparation method thereof | |
| KR20170009702A (en) | Wet wipes composition and wet wipes containing the same including the troplone | |
| KR101788179B1 (en) | Low irritation skin external application composition with an improved antiseptic ability | |
| JP5264829B2 (en) | Antiseptic disinfectant and cosmetic composition | |
| Strilets et al. | A study of antimicrobial activity of foam-washing agent specimens at acidic pH values | |
| JP2007145748A (en) | Antiseptic sterilizer, cosmetic or medicine containing the antiseptic sterilizer, and method for antiseptic sterilization |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170322 |